Mirum Pharmaceuticals Inc

NASDAQ:MIRM   3:59:40 PM EDT
17.48
-0.01 (-0.06%)
Earnings Announcements

Mirum Pharmaceuticals Reports Q4 Loss Per Share Of $1.43

Published: 03/09/2021 22:53 GMT
Mirum Pharmaceuticals Inc (MIRM) - Mirum Pharmaceuticals Reports Fourth Quarter and Year-end 2020 Results and Provides Business Updates.
Q4 Loss per Share $1.43.
Q4 Earnings per Share Estimate $-0.97 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.16

Next Quarter Revenue Guidance is expected to be $0.11 Million
Next Quarter EPS Guidance is expected to be -$1.29

More details on our Analysts Page.